论文部分内容阅读
目的:观察分析血液透析联合血液灌流治疗尿毒症并发症的临床疗效。方法:选取2014年8月至2016年8月在我院接受治疗的尿毒症患者28例进行研究,按照治疗方法的不同分为血透组与参照组,每组14例,参照组采用单纯的血液透析治疗,血透组采用血液透析联合血液灌流治疗,治疗结束后,对比分析两组患者的临床症状改善率以及不良反应发生率。结果:通过对比发现,血透组患者的临床症状改善率高于参照组,不良反应发生率低于参照组,两组差异显著(P<0.05),具有统计学意义。结论:血液透析联合血液灌流治疗尿毒症并发症有显著的临床效果,不良反应较少,值得临床推广应用。
Objective: To observe and analyze the clinical efficacy of hemodialysis combined with hemoperfusion in the treatment of uremia complications. Methods: A total of 28 uremic patients treated in our hospital from August 2014 to August 2016 were selected and divided into the hemodialysis group and the reference group according to the different treatment methods. Each group included 14 patients and the reference group was simple Hemodialysis treatment, hemodialysis group with hemodialysis combined with hemoperfusion treatment, after treatment, comparative analysis of two groups of patients with clinical symptom improvement rate and the incidence of adverse reactions. Results: The results showed that the improvement rate of clinical symptoms in patients with hemodialysis was higher than that of the reference group and the incidence of adverse reactions was lower than that of the reference group. There was significant difference between the two groups (P <0.05). Conclusion: Hemodialysis combined with hemoperfusion treatment of uremia complications have significant clinical effects, fewer adverse reactions, it is worthy of clinical promotion and application.